Effect of dialyser membrane pore size on plasma homocysteine levels in haemodialysis patients.

Abstract

BACKGROUND Hyperhomocysteinaemia is a putative risk factor for atherothrombotic cardiovascular disease in the haemodialysis population. High-dose vitamin B therapy does not entirely normalize elevated plasma total homocysteine (tHcy) levels in haemodialysis patients. Alternative therapies to reduce tHcy further are therefore required. Modifications of the… (More)

Topics

5 Figures and Tables

Cite this paper

@article{Vriese2003EffectOD, title={Effect of dialyser membrane pore size on plasma homocysteine levels in haemodialysis patients.}, author={An Sabine De Vriese and Michel R. Langlois and D. T. Bernard and Inge Geerolf and Lut Stevens and Johan R. Boelaert and Mario S Schurgers and Erve G Matthys}, journal={Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association}, year={2003}, volume={18 12}, pages={2596-600} }